We’re closely following recent changes to U.S. Section 338 tariffs and how it will affect some life sciences companies exporting to the United States.
Effective October 30, the U.S. expanded the list of Canadian products subject to an additional 50% duty, including certain diagnostic reagents and laboratory products that are relevant to parts of our sector. While not every company will be directly impacted, many founders are evaluating what these changes could mean for customers, pricing, supply chains, and future growth.
Ready to Help Local Companies
As trade conditions continue to evolve, understanding your company’s exposure and options is increasingly important. Life Sciences Nova Scotia is committed to helping members navigate this uncertainty and connect them with resources that can support informed business decisions.
Whether you’re assessing potential tariff impacts, exploring new markets, or reviewing your export strategy, there are programs and funding available to help.
Resources Available to Members
Invest Nova Scotia’s Tariff and Customs Advisory Program (TCAP)
TCAP helps Atlantic Canadian exporters access expert guidance from customs brokers, trade consultants, and trade lawyers. Eligible companies can receive up to $10,000 in non-repayable consulting support to better understand tariff exposure, navigate customs requirements, assess supply chain options, and explore strategies to reduce trade-related risks.
ACOA’s Regional Tariff Response Initiative (RTRI)
The Regional Tariff Response Initiative provides support for businesses affected by tariffs and ongoing trade disruption.
Funding may be available to help companies maintain operations, strengthen competitiveness, diversify markets, improve productivity, and build long-term resilience. The program also recognizes that tariff impacts can extend beyond direct exporters and affect companies throughout the broader supply chain.